DrugSpace Symposium Spring 2023

Connect the Dots for Future Drug Discovery

In our third virtual BioSolveIT DrugSpace Symposium, focus is placed on the recent trends that transform modern drug discovery: machine learning, artificial intelligence, neural networks, and processing big data.
Can recent developments live up to the hype around AI, or is there still a long way to go? This event brings researchers together who aim to discover future drug candidates from a myriad of data flows. An exciting journey lies ahead of us!

Medicinal chemists, decision makers, representatives of crop-, pharmaceutical-, and medicine-related businesses, undergraduates and PhD students, researchers — simply anyone interested in future technologies and state-of-the-art drug development — you are cordially invited to participate in this virtual event. Again, this BioSolveIT Symposium aims to be accessible to the entire global research community; BioSolveIT takes pride in thanking all brilliant speakers and participants for their contribution to the event in advance.

The third DrugSpace Symposium takes place on 24 and 25th May, 2023 — starting daily at 3 pm CEST/Berlin. Registration and participation is free-of-charge.

Register for free for the DrugSpace 2023 Symposium

DrugSpace 2023 Programme

Once again, we are very proud to host renowned experts in their fields from around the globe, contributing their knowledge to the scientific community.
DrugSpace 2023 Programme (PDF)

Follow Us on Social Media

Don't want to miss the latest BioSolveIT updates on upcoming events, success stories, and software updates?
Follow us on our social media channels, and be always up-to-date with the latest developments in the drug discovery community.
LinkedIn Youtube Twitter Facebook
Join the Chemical Space Club

Join the Chemical Space Club

Enthusiasts of Chemical Spaces are invited to join the Chemical Space Club on LinkedIn.

Share information, early announcements, publications, success stories, and anything else related to huge chemistry spaces and databases. Become a member, and feel free to contribute.
Learn More

Confirmed Speakers

  • Philippe Schwaller
    (École Polytechnique Fédérale de Lausanne)
    "AI-Accelerated Organic Synthesis"
  • Quentin Perron
    (Iktos)
    "Yes, You Should Use AI for Medicinal Chemistry"
  • Léa El Khoury
    (Qubit)
    "Application of Absolute Binding Free Energy Calculations to Predict the Binding Modes and Affinities of Protein-Protein Inhibitors"
  • Francesca Grisoni
    (Eindhoven University of Technology)
    "Deep Learning for Drug Discovery: Challenges and Opportunities"
  • Marcus Gastreich
    (BioSolveIT)
    "Claw Machines for Exploding Chemical Spaces"
  • Yurri Moroz
    (Chemspace)
    "Making Virtual REAL: Creation and Use of the Giga-Scale Chemical Spaces"
  • Dusan Petrovic
    (Nuvisan)
    "Virtual Screening for Multiple Modalities"
  • Connor Coley
    (Massachusetts Institute of Technology)
    "Learning to Navigate Synthetically Accessible Chemical Space"
  • Henry van den Bedem
    (Atomwise)
    "An Efficient Graph Generative Model for Navigating Ultra-Large Combinatorial Synthesis Libraries"
  • Nick Antonopoulos
    (DeepLab)
    "Scalable and High-Throughput Deep Neural Virtual Screening"
  • Lewis Martin
    (OpenBench)
    "Fast and Economical Hit Finding with Active Learning"
  • Daniel Kuhn
    (Merck)
    "You Can't Improve What You Don't Measure — Measuring ML/AI Impact in Drug Discovery Projects"
  • Christoph Grebner
    (Sanofi)
    "AI-Driven Mining of Accessible Chemical Spaces"

Latest news
"A Gaze into Chemical Space" Series
April 16, 2024 11:26 CEST
Introducing our latest series, “A Gaze into Chemical Space,” where we explore the expansive realms of combinatorial compound collections. Our aim in this exercise is to uncover similar compounds of potential and approved drugs using various methods. Typically, several synthesis steps are required to get to a compound with favorable...
Read on
Behind the Scenes of Enamine's REAL Space
April 15, 2024 16:43 CEST
Since its launch in 2018, Enamine’s REAL Space has made a significant impact in revolutionizing the landscape of compound collections. The initial version contained approximately 650 million compounds, establishing itself as one of the expansive catalogs of commercially available molecules for drug discovery. Notably, the first release rivaled even the...
Read on
category
Webinars
A Novel Class of SARS-CoV-2 Mpro Inhibitors: Systematic Design, Synthesis, Biological Evaluation, Antiviral Activity, and Structural Insights
Thu, 25 Apr 2024, 16:00 CEST (Berlin)
COVID-19 is shifting from pandemic to endemic, but the etiological agent, SARS-CoV-2, is still spreading and causing public health issues around the world. New variants, with multiple mutations in their spike proteins, are now able to evade neutralization by antibodies in vaccinated and convalescent individuals. Consequently, there is a pressing...
Read on